Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley +1 more source
Liquid biopsy in biliary tract cancers: early diagnosis, precision therapy, and prognostic evaluation. [PDF]
Wu G, Xu X, Zhang H, Peng L, Liu C.
europepmc +1 more source
[Biliary tract diseases. Current trends biliary tract imaging].
openaire +1 more source
Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman +3 more
wiley +1 more source
Recapitulating Liver Embryology-Lessons to Be Learned for Liver Diseases. [PDF]
Oliveira RC +3 more
europepmc +1 more source
Clinical Practice Guidelines for Peroral Cholangioscopy. [PDF]
Nagai K +13 more
europepmc +1 more source
Mixed cholangiopathy with eosinophilic and autoimmune features: a case report. [PDF]
Shen H +4 more
europepmc +1 more source
Innate immunity of bile and cholangiocytes in primary biliary cholangitis. [PDF]
Chen R, Sun Y, Hu Y, Tai W.
europepmc +1 more source
Biliary drainage in patients with altered anatomy: Literature review of different endoscopic approaches. [PDF]
Cocca S +13 more
europepmc +1 more source
Hepatobiliary alveolar echinococcosis treated with delayed resection following percutaneous drainage. [PDF]
Quan S +5 more
europepmc +1 more source

